ArticleCellular oncology (Dordrecht, Netherlands)2019

The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells.

Majid Momeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.